After the implementation of strategic pricing adjustment the ratio of new Hims & Hers loss subscribers that selected a personalized offering with the duration of five months or more, increased over 25 points during the course of the second quarter.

Source: https://seekingalpha.com/article/4625156-hims-and-health-inc-hims-q2-2023-earnings-call-transcript?source=feed_all_articles

Further, he said with the country’s “vibrant” IT industry despite the continuing impact of the global slowdown in trade, Himap remains “bullish” in projecting a 13-percent to 15-percent growth for Hims FDI and exports this year.

Source: https://businessmirror.com.ph/2023/04/25/peza-banks-on-marcos-trips-to-lure-healthcare-investors/

Hims has demonstrated their ability to maintain high levels of growth, and the company has the potential to smash their 2025 revenue guidance if they continue to execute.

Source: https://seekingalpha.com/article/4614816-hims-and-hers-health-stock-double-edged-sword?source=feed_all_articles

Once you get your prescription, Hims will have your medication delivered discreetly and directly to you.

Source: https://www.healthcanal.com/health/hims-review

Research analysts forecast that Hims & Hers Health, Inc. will post -0.13 EPS for the current year.

Source: https://www.etfdailynews.com/2023/04/08/insider-selling-hims-hers-health-inc-nysehims-insider-sells-15890-shares-of-stock/

While Hims remains GAAP unprofitable, they have posted positive adjusted EBITDA over the past two quarters which is a step in the right direction.

Source: https://seekingalpha.com/article/4614816-hims-and-hers-health-stock-double-edged-sword?source=feed_all_articles